Portfolio Company · Operating Co.
Company Snapshot
Kirilys is a life sciences / oncology portfolio company held by Tarsadia Investments. Profile compiled from public sources; submit updates to extend the public record.
SectorLife Sciences / Oncology
Parent PE firmTarsadia Investments
Ownership statusCurrent
WebsiteVisit ↗
Ownership Context
Kirilys is a current portfolio company of Tarsadia Investments. Public coverage of this company is grouped under its parent firm's profile.
Sources
https://tarsadia.com/portfolioThis profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Kirilys and does not provide investment advice.
Other portfolio companies of Tarsadia Investments
Amneal Pharmaceuticals
Pharmaceuticals
Asana Biosciences
Life Sciences / Biotech
AvantStay
Real Estate / Hospitality
Bolttech
Fintech / Insurtech
Brightvine
Fintech / Web3
ChronicleBio
Healthcare / Techbio
Citadel Access Solutions
Commercial Services / Access Control
ClinTrial Research
Healthcare Services
See the full Tarsadia Investments portfolio.